- Expertise article
- Angulo et al., 2012
PRRSv has been demonstrated to have an economical per pig up to $9.12 US dollars in nursery phase. Modified-live virus vaccine represents a viable option to minimize the negative impact of PRRS in growing pigs in production systems. The objective of this project was to determine if strategic use of Ingelvac ® PRRS MLV could improve growing pig performance and reduce mortality compared to the previous 24 months of production data in a large-scale pig production.
Read the full publication here.